Abbas Yazdanbod
Overview
Explore the profile of Abbas Yazdanbod including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
613
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdi E, Latifi-Navid S, Kholghi-Oskooei V, Mostafaiy B, Pourfarzi F, Yazdanbod A
BMC Cancer
. 2024 Nov;
24(1):1440.
PMID: 39578780
Background: Improper expression of long noncoding RNAs (lncRNAs) can cause various cancers. Single nucleotide polymorphisms (SNPs) affect the expression and function of several key lncRNAs. We assessed the associations of...
2.
Hasani S, Pourfarzi F, Mazani M, Yazdanbod A, Fazaeli A
Genet Test Mol Biomarkers
. 2024 Oct;
28(11):445-451.
PMID: 39377150
Gastric cancer's (GC) cause is unknown, but its complexity indicates that, in addition to environmental factors, it may have genetic origins. Scientists are studying single-nucleotide polymorphisms (SNPs) in the antisense...
3.
Javanbakhat P, Hosseinali Z, Nemati R, Yazdanbod A, Teimourpour R
Indian J Gastroenterol
. 2024 Oct;
PMID: 39367953
No abstract available.
4.
Pourfarzi F, Rashidi M, Yazdanbod A, Nemati A, Dogaheh H, Faghfuri E, et al.
Trials
. 2024 Sep;
25(1):617.
PMID: 39300505
Background: In addition to Helicobacter pylori (H. pylori) infection eradication, some medications, including aspirin, metformin, and statins, have been suggested to have protective effects against gastric cancer (GC) development in...
5.
Momayez Sanat Z, Vahedi H, Malekzadeh R, Kasaeian A, Mohammadi Ganjaroudi N, Sima A, et al.
Arch Iran Med
. 2024 Jul;
27(7):350-356.
PMID: 39072382
Background: Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) marked by rectal and colon inflammation, leading to relapsing symptoms. Its prevalence is increasing, particularly in developed nations,...
6.
Sadeghi A, Boustani P, Mehrpour A, Ali Asgari A, Sharafkhah M, Yazdanbod A, et al.
PLoS One
. 2024 Jul;
19(7):e0306223.
PMID: 38990911
Background: This study assessed the prevalence of gastroesophageal reflux disease (GERD) in a general adult population in Iran. The association between GERD and various factors was also evaluated. Methods: We...
7.
Khanmohammadi S, Sheidaei A, Alatab S, Tabatabaei-Malazy O, Vahedi H, Mansour-Ghanaei F, et al.
PLoS One
. 2024 Jul;
19(7):e0304792.
PMID: 38990835
Background: Despite the rising prevalence of Inflammatory Bowel Disease (IBD), age and sex differences in its outcomes remain understudied. We investigated age and sex differences in IBD patients using a...
8.
Saberzadeh-Ardestani B, Khosravi A, Mansour-Ghanaei F, Vahedi H, Baniasadi N, Seyyedmajidi M, et al.
Arch Iran Med
. 2024 Apr;
27(4):183-190.
PMID: 38685844
Background: Data on the epidemiology of inflammatory bowel disease (IBD) in the Middle East are scarce. We aimed to describe the clinical phenotype, disease course, and medication usage of IBD...
9.
Raei N, Yazdanbod A, Latifi-Navid S, Safaralizadeh R
Nucleosides Nucleotides Nucleic Acids
. 2024 Feb;
43(12):1459-1471.
PMID: 38386862
LncRNA SNHG15 has been recognized as the main factor in the progression of various cancer types. However, the underlying mechanisms are not well clarified. This research aimed to explore the...
10.
Vosoghinia H, Saberzadeh-Ardestani B, Anushiravani A, Mansour-Ghanaei F, Fakheri H, Vahedi H, et al.
Arch Iran Med
. 2024 Feb;
26(9):481-488.
PMID: 38310403
Background: It is unknown if the clinical manifestations and phenotype of disease are comparable between early- and elderly-onset inflammatory bowel disease (IBD). We aimed to seek differences in disease phenotype,...